# Correlation Between Tumor-infiltrating Lymphocytes and Response to Systemic Therapy in Breast Cancer

> **NCT07404462** · — · COMPLETED · sponsor: **Institute of Oncology Ljubljana** · enrollment: 171 (actual)

## Conditions studied

- Breast Cancer
- Early Breast Cancer

## Interventions

- **OTHER:** Standard-of-Care Neoadjuvant Chemotherapy

## Key facts

- **NCT ID:** NCT07404462
- **Lead sponsor:** Institute of Oncology Ljubljana
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 171 (ACTUAL)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07404462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07404462, "Correlation Between Tumor-infiltrating Lymphocytes and Response to Systemic Therapy in Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07404462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*